Three novel β-carboline alkaloids from Gelsemium elegans.
Zhen Zhang1, Yu Zhang, Yue-Hu Wang
1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, People's Republic of China.
Fitoterapia
|March 13, 2012
Summary
Researchers discovered three new β-carboline alkaloids, named gelebolines A-C, from Gelsemium elegans roots. This marks the first report of β-carbolines in the Gelsemium genus, expanding knowledge of plant-derived compounds.
Area of Science:
- Natural Product Chemistry
- Phytochemistry
- Organic Chemistry
Background:
- Gelsemium elegans is a plant species known for its medicinal properties.
- Alkaloids are a diverse class of naturally occurring organic compounds that are particularly known for their pharmacological effects.
- Previous phytochemical investigations of Gelsemium species have identified various alkaloids, but β-carbolines have not been reported.
Purpose of the Study:
- To isolate and characterize novel chemical constituents from the roots of Gelsemium elegans.
- To investigate the potential presence of β-carboline alkaloids within the Gelsemium genus.
- To elucidate the structures of newly discovered compounds using spectroscopic techniques.
Main Methods:
- Extraction of compounds from Gelsemium elegans root material.
- Chromatographic separation techniques (e.g., HPLC) for isolation of individual alkaloids.
- Spectroscopic analysis, including NMR and Mass Spectrometry, for structural elucidation.
Main Results:
- Three new β-carboline alkaloids, designated gelebolines A-C (1-3), were isolated.
- These novel alkaloids possess a unique degraded monoterpenoid moiety.
- Eleven known alkaloids of various structural types were also identified from the plant extract.
Conclusions:
- The isolation of gelebolines A-C represents the first documented instance of β-carboline alkaloids in the Gelsemium genus.
- The findings expand the known chemical diversity of Gelsemium species and contribute to the understanding of β-carboline biosynthesis.
- This study provides a foundation for further research into the biological activities and potential applications of these novel compounds.
Related Concept Videos
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
01:28Classification of Skeletal Muscle Relaxants
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:24Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.